Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313252203> ?p ?o ?g. }
- W4313252203 endingPage "800" @default.
- W4313252203 startingPage "788" @default.
- W4313252203 abstract "The COVID-19 pandemic and the need for additional safe, effective, and affordable vaccines gave new impetus into development of vaccine genetic platforms. Here we report the findings from the phase 1, first-in-human, dose-escalation study of COVID-eVax, a DNA vaccine encoding the receptor binding domain (RBD) of the SARS-CoV-2 spike protein. Sixty-eight healthy adults received two doses of 0.5, 1, or 2 mg 28 days apart, or a single 2-mg dose, via intramuscular injection followed by electroporation, and they were monitored for 6 months. All participants completed the primary safety and immunogenicity assessments after 8 weeks. COVID-eVax was well tolerated, with mainly mild to moderate solicited adverse events (tenderness, pain, bruising, headache, and malaise/fatigue), less frequent after the second dose, and it induced an immune response (binding antibodies and/or T cells) at all prime-boost doses tested in up to 90% of the volunteers at the highest dose. However, the vaccine did not induce neutralizing antibodies, while particularly relevant was the T cell-mediated immunity, with a robust Th1 response. This T cell-skewed immunological response adds significant information to the DNA vaccine platform and should be assessed in further studies for its protective capacity and potential usefulness also in other therapeutic areas, such as oncology." @default.
- W4313252203 created "2023-01-06" @default.
- W4313252203 creator A5000280939 @default.
- W4313252203 creator A5004022534 @default.
- W4313252203 creator A5004593464 @default.
- W4313252203 creator A5011871245 @default.
- W4313252203 creator A5012765772 @default.
- W4313252203 creator A5015058883 @default.
- W4313252203 creator A5020552273 @default.
- W4313252203 creator A5020699728 @default.
- W4313252203 creator A5029398339 @default.
- W4313252203 creator A5039478049 @default.
- W4313252203 creator A5041668420 @default.
- W4313252203 creator A5044577823 @default.
- W4313252203 creator A5045653936 @default.
- W4313252203 creator A5047692961 @default.
- W4313252203 creator A5049488264 @default.
- W4313252203 creator A5053809391 @default.
- W4313252203 creator A5056806678 @default.
- W4313252203 creator A5059750492 @default.
- W4313252203 creator A5060641380 @default.
- W4313252203 creator A5070486956 @default.
- W4313252203 creator A5074295067 @default.
- W4313252203 creator A5075603970 @default.
- W4313252203 creator A5078728203 @default.
- W4313252203 creator A5080545418 @default.
- W4313252203 creator A5080933580 @default.
- W4313252203 creator A5087089921 @default.
- W4313252203 creator A5089676253 @default.
- W4313252203 date "2023-03-01" @default.
- W4313252203 modified "2023-10-05" @default.
- W4313252203 title "A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19" @default.
- W4313252203 cites W1967142154 @default.
- W4313252203 cites W2009056434 @default.
- W4313252203 cites W2022953507 @default.
- W4313252203 cites W2023520005 @default.
- W4313252203 cites W2038042144 @default.
- W4313252203 cites W2052649413 @default.
- W4313252203 cites W2061829061 @default.
- W4313252203 cites W2115596188 @default.
- W4313252203 cites W2122334110 @default.
- W4313252203 cites W2145090231 @default.
- W4313252203 cites W2158112090 @default.
- W4313252203 cites W2177843988 @default.
- W4313252203 cites W2942484034 @default.
- W4313252203 cites W2948325732 @default.
- W4313252203 cites W2963951165 @default.
- W4313252203 cites W3016900702 @default.
- W4313252203 cites W3022376279 @default.
- W4313252203 cites W3045578670 @default.
- W4313252203 cites W3086125063 @default.
- W4313252203 cites W3097610605 @default.
- W4313252203 cites W3108193091 @default.
- W4313252203 cites W3115068672 @default.
- W4313252203 cites W3119345685 @default.
- W4313252203 cites W3141087105 @default.
- W4313252203 cites W3149674978 @default.
- W4313252203 cites W3157661219 @default.
- W4313252203 cites W3160683687 @default.
- W4313252203 cites W3162400064 @default.
- W4313252203 cites W3164547793 @default.
- W4313252203 cites W3170241852 @default.
- W4313252203 cites W3183388359 @default.
- W4313252203 cites W3184118161 @default.
- W4313252203 cites W3197071042 @default.
- W4313252203 cites W3210401977 @default.
- W4313252203 cites W4200455332 @default.
- W4313252203 cites W4207048578 @default.
- W4313252203 cites W4210493562 @default.
- W4313252203 cites W4212835565 @default.
- W4313252203 cites W4224232962 @default.
- W4313252203 cites W4226287603 @default.
- W4313252203 cites W4282576863 @default.
- W4313252203 doi "https://doi.org/10.1016/j.ymthe.2022.12.017" @default.
- W4313252203 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36575794" @default.
- W4313252203 hasPublicationYear "2023" @default.
- W4313252203 type Work @default.
- W4313252203 citedByCount "4" @default.
- W4313252203 countsByYear W43132522032023 @default.
- W4313252203 crossrefType "journal-article" @default.
- W4313252203 hasAuthorship W4313252203A5000280939 @default.
- W4313252203 hasAuthorship W4313252203A5004022534 @default.
- W4313252203 hasAuthorship W4313252203A5004593464 @default.
- W4313252203 hasAuthorship W4313252203A5011871245 @default.
- W4313252203 hasAuthorship W4313252203A5012765772 @default.
- W4313252203 hasAuthorship W4313252203A5015058883 @default.
- W4313252203 hasAuthorship W4313252203A5020552273 @default.
- W4313252203 hasAuthorship W4313252203A5020699728 @default.
- W4313252203 hasAuthorship W4313252203A5029398339 @default.
- W4313252203 hasAuthorship W4313252203A5039478049 @default.
- W4313252203 hasAuthorship W4313252203A5041668420 @default.
- W4313252203 hasAuthorship W4313252203A5044577823 @default.
- W4313252203 hasAuthorship W4313252203A5045653936 @default.
- W4313252203 hasAuthorship W4313252203A5047692961 @default.
- W4313252203 hasAuthorship W4313252203A5049488264 @default.
- W4313252203 hasAuthorship W4313252203A5053809391 @default.
- W4313252203 hasAuthorship W4313252203A5056806678 @default.
- W4313252203 hasAuthorship W4313252203A5059750492 @default.